FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

329165006: Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
467303017 Hydroxyapatite 830mg tablet en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
720056017 Hydroxyapatite 830mg tablet (substance) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
1191731017 Hydroxyapatite 830mg tablet (product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
3489573010 Product containing hydroxyapatite 830 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3491457017 Product containing hydroxyapatite 830 mg/1 each oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3500943011 Hydroxyapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3567213010 Product containing only hydroxyapatite 830 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3567214016 Product containing only hydroxyapatite 830 mg/1 each oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3679650010 Product containing precisely hydroxyapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
3679651014 Product containing precisely hydroxyapatite 830 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT core
4042410014 Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4042411013 Durapatite 830 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2457571000005113 hydroxylapatit, tablet med 830 mg da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
3616541000005118 hydroxylapatit tablet 830 mg da Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4705491000005114 hydroxylapatit 830 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite-containing product false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Mineral supplement (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. næringsstoftilskud false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. middel til urogenital anvendelse false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Durapatite (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Nutritional supplement (substance) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. hydroxyapatit false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. hydroxyapatit false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. hydroxyapatit false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength numerator value 830 false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). hydroxyapatit false Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite-containing product in oral dose form false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Count of base of active ingredient en false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Calcium phosphate only product in oral dose form false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product false Inferred relationship Some
Hydroxyapatite 830 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Durapatite (substance) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Durapatite (substance) true Inferred relationship Some 1
Hydroxyapatite 830 mg oral tablet Is a Hydroxyapatite only product in oral dose form true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start